Facing imminent loss of exclusivity for multiple brands in its immunology/transplant portfolio, our client sought to fill the anticipated gap through business development. Acsel partnered with the client team to assess how to best preserve the current business, adding value in the short term with synergistic products and in the long term with disruptive products and technologies.
To address this complex challenge for our client, the Acsel team applied deep experience in the hospital channel as well as transplant and immunology to:
Identify the relevant evolving and high impact hospital trends over the next 1-3 years
Working closely with our client, Acsel crafted a sustainable, well supported hospital franchise plan and enabled appropriate strategic decisions to leverage internal capabilities and infrastructure.